| Price | 70.50p on 07-11-2025 at 19:40:05 |
|---|---|
| Change | -2.50p -3.42% |
| Buy | 71.00p |
| Sell | 70.00p |
| Last Trade: | Sell 45,000.00 at 71.928p |
| Day's Volume: | 1,709,409 |
| Last Close: | 70.50p |
| Open: | 73.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 70.50p - 73.40p |
| 52wk Range: | 27.25p - 75.00p |
| Market Capitalisation: | £305.73m |
| VWAP: | 72.01128p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 45,000 | 71.928p | Negotiated Trade |
16:53:39 - 07-Nov-25 |
| Buy* | 500 | 70.675p | Ordinary |
16:29:54 - 07-Nov-25 |
| Buy* | 6,280 | 70.70p | Ordinary |
16:28:14 - 07-Nov-25 |
| Buy* | 500 | 70.7465p | Ordinary |
16:28:00 - 07-Nov-25 |
| Sell* | 2,000 | 70.00p | Ordinary |
16:27:52 - 07-Nov-25 |
| Buy* | 204 | 70.75p | Ordinary |
16:26:25 - 07-Nov-25 |
| Sell* | 24,733 | 70.111p | Ordinary |
16:26:22 - 07-Nov-25 |
| Buy* | 2,500 | 71.00p | Ordinary |
16:17:05 - 07-Nov-25 |
| Buy* | 2,500 | 71.00p | Ordinary |
16:16:22 - 07-Nov-25 |
| Buy* | 2,500 | 71.00p | Ordinary |
16:14:25 - 07-Nov-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
| 15th Sep 2025 7:00 am | RNS | Notice of Interim Results |
| 9th Sep 2025 7:00 am | RNS-R | Shortlisted for AIM Awards Technology of the Year |
